Empagliflozin in Heart Failure with a Preserved Ejection Fraction

In a randomized trial, 5988 patients with heart failure with preserved ejection fraction were assigned to receive either empagliflozin or placebo in addition to usual therapy. At a median of 26 months, the empagliflozin group had a lower incidence of cardiovascular death or hospitalization for heart...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	The New England journal of medicine Ročník 385; číslo 16; s. 1451 - 1461
Hlavní autori:	Anker, Stefan D, Butler, Javed, Filippatos, Gerasimos, Ferreira, João P, Bocchi, Edimar, Böhm, Michael, Brunner–La Rocca, Hans-Peter, Choi, Dong-Ju, Chopra, Vijay, Chuquiure-Valenzuela, Eduardo, Giannetti, Nadia, Gomez-Mesa, Juan Esteban, Janssens, Stefan, Januzzi, James L, Gonzalez-Juanatey, Jose R, Merkely, Bela, Nicholls, Stephen J, Perrone, Sergio V, Piña, Ileana L, Ponikowski, Piotr, Senni, Michele, Sim, David, Spinar, Jindrich, Squire, Iain, Taddei, Stefano, Tsutsui, Hiroyuki, Verma, Subodh, Vinereanu, Dragos, Zhang, Jian, Carson, Peter, Lam, Carolyn Su Ping, Marx, Nikolaus, Zeller, Cordula, Sattar, Naveed, Jamal, Waheed, Schnaidt, Sven, Schnee, Janet M, Brueckmann, Martina, Pocock, Stuart J, Zannad, Faiez, Packer, Milton
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	United States Massachusetts Medical Society 14.10.2021
Predmet:	Adult Antidiabetics Benzhydryl Compounds - administration & dosage Benzhydryl Compounds - adverse effects Cardiology Cardiology and cardiovascular system Cardiology General Cardiovascular diseases Cardiovascular Diseases - mortality Cardiovascular Diseases - prevention & control Chronic Disease Congestive heart failure Diabetes Diabetes mellitus Double-Blind Method Ejection fraction Female Glucosides - administration & dosage Glucosides - adverse effects Heart Failure Heart Failure - drug therapy Heart Failure - physiopathology Hospitalization - statistics & numerical data Human health and pathology Humans Hypotension Life Sciences Male Patient safety Placebos Sodium-glucose cotransporter Sodium-Glucose Transporter 2 Inhibitors - administration & dosage Sodium-Glucose Transporter 2 Inhibitors - adverse effects Statistical analysis Stroke Volume Urinary tract
ISSN:	0028-4793, 1533-4406, 1533-4406
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!